Several studies have demonstrated that activating TLR2 leads to an increase in the aggregation of amyloid proteins, whereas inhibiting TLR2 reduces the levels of neuronal Aβ in the AD mouse model [132,133]. Here, TLR2 is linked to Alzheimer disease.